Medicated Skin Care in Japan

Date: April 30, 2012
Pages: 48
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ME3EEC7FD53EN
Leaflet:

Download PDF Leaflet

Value sales of vaginal antifungals rose by 6% in 2011. Female consumers are switching from prescription to OTC medications due to the sensitive nature of a vaginal yeast infection. Te self-medication trend is growing in vaginal antifungals as consumers prefer purchasing OTC medicines rather than consulting a doctor, in order to keep the symptoms more private. As an increasing number of women are entering the workforce, the level of stress is rising and an associated reduction in the...

Euromonitor International's Medicated Skin Care in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Daiichi Sankyo Healthcare Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
  Summary 2 Daiichi Sankyo Healthcare Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2011
Hisamitsu Pharmaceutical Co Inc in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts
  Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2011
Kobayashi Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 7 Kobayashi Pharmaceutical Co Ltd: Key Facts
  Summary 8 Kobayashi Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 9 Kobayashi Pharmaceutical Co Ltd: Competitive Position 2011
Nichiban Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 10 Nichiban Co Ltd: Key Facts
  Summary 11 Nichiban Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 12 Nichiban Co Ltd: Competitive Position 2011
Otsuka Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 13 Otsuka Pharmaceutical Co Ltd: Key Facts
  Summary 14 Otsuka Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 15 Otsuka Pharmaceutical Co Ltd: Competitive Position 2011
Rohto Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 16 Rohto Pharmaceutical Co Ltd: Key Facts
  Summary 17 Rohto Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 18 Rohto Pharmaceutical Co Ltd: Competitive Position 2011
Sato Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 19 Sato Pharmaceutical Co Ltd: Key Facts
  Summary 20 Sato Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 21 Sato Pharmaceutical Co Ltd: Competitive Position 2011
Taisho Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 22 Taisho Pharmaceutical Co Ltd: Key Facts
  Summary 23 Taisho Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 24 Taisho Pharmaceutical Co Ltd: Competitive Position 2011
Takeda Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 25 Takeda Pharmaceutical Co Ltd: Key Facts
  Summary 26 Takeda Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 27 Takeda Pharmaceutical Co Ltd: Competitive Position 2011
Executive Summary
High Pollen Levels Push Up Sales of Anti-pollen Positioned Products
March Earthquake Has Limited Impact on Consumer Health Industry
OTC Switch Creates A Major Hit Product - Loxonin S
Collagen Becomes A Beauty Catalyst Among Female Consumers
Competition Poses A Threat To Sales of Tonics and Bottled Nutritive Drinks
Key Trends and Developments
High Pollen Levels in 2011
Rising National Debt and Potential for OTC Switches
Delivery Service by Parapharmacies/drugstores
Electronic Tracking of Customer Medication Usage
Increasing Non-store Retailing Channel Sales
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Consumer Healthcare Registration
Consumer Healthcare Advertising
Consumer Healthcare Packaging
Consumer Healthcare Distribution
Regulation of Japanese Traditional Herbal Remedies (kampo)
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 28 OTC Switches 2009-2011
Definitions
Sources
  Summary 29 Research Sources
Skip to top


Medicated Skin Care in Egypt US$ 990.00 Nov, 2012 · 23 pages

Ask Your Question

Medicated Skin Care in Japan
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: